Average Co-Inventor Count = 4.49
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. 3-dimensional Pharmaceuticals, Inc. (9 from 76 patents)
2. Janssen Pharmaceutica Nv (4 from 2,077 patents)
13 patents:
1. 9815790 - Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists
2. 8883473 - Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases
3. 8798939 - Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinases
4. 8753857 - Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor
5. 7138374 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137
6. 6767722 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137
7. 6737404 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137
8. 6569631 - Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes
9. 6291192 - Method for identifying conditions that facilitate recombinant protein folding
10. 6291191 - Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization
11. 6274712 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
12. 6268158 - Method for determining conditions that facilitate protein crystallization
13. 6232085 - Method for determining conditions that stabilize proteins